|
|
|
|
|
|
|
|
|
|
|
|
|
14.04.26 - 15:54
|
Axonex Intelligence′s AI Robotics Series Makes a Splash at InnoEX Featuring NEX′s Debut in Hong Kong As AXONEX Showcases Its Latest Robotics Portfolio (GlobeNewswire EN)
|
|
|
Hong Kong, April 14, 2026 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (“Mint” or the “Group”, NASDAQ: MIMI), a Hong Kong-based company with a new strategic focus on artificial intelligence (“AI”) and robotics, and an established business interior design and fit-out works provider, today announced that its wholly-owned subsidiary, Axonex Intelligence Limited ("AXONEX"), is participating in the Hong Kong International Creative & Technology Expo (“InnoEX”), organized by the Hong Kong Trade Development Council (“HKTDC”). InnoEX is being held from April 13 to 16, 2026, at the Hong Kong Convention and Exhibition Centre. As an annual flagship innovation and technology event in Asia, InnoEX brings together cutting-edge technologies and smart solutions from around the world and serves as a key platform for cross-sector collaboration and business matching. This year's edition places a strong focus on AI and robotics. AXONEX is showcasing its latest series of robotics products at ...
|
|
|
|
|
|
|
|
|
|
|
|
|
14.04.26 - 15:30
|
Performance Shipping Inc. Announces Sale of 2010-Built Aframax Vessel M/T P. Aliki for US$42.65 Million (GlobeNewswire EN)
|
|
|
ATHENS, Greece, April 14, 2026 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today announced that, through a separate wholly-owned subsidiary, it has signed a Memorandum of Agreement to sell its oldest vessel, the 2010-built, 105,304 dwt Aframax tanker vessel, M/T P. Aliki, to Trafigura Maritime Logistics Pte. Ltd. for a gross sale price of US$42.65 million. The vessel is expected to be delivered to the new owners in or around the end of the third quarter 2026, subject to customary closing conditions and upon expiration of her current US$30,000 per day time charter with Pakistan National Shipping Corporation....
|
|
|
|
|
14.04.26 - 15:18
|
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan (GlobeNewswire EN)
|
|
|
SALT LAKE CITY, April 14, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the use of the MyChoice® Test for prostate cancer patients as a companion diagnostic for Lynparza® (olaparib). With this approval, clinicians can now order the MyChoice Test to determine homologous recombination deficiency (HRD) status for patients with ovarian cancer, and BRCA1/2 status for breast and prostate cancers....
|
|
|
|
|
|
|
|
|
|
|
|
|
|